BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He W, Xing X, Wang X, Wu D, Wu W, Guo J, Mitragotri S. Nanocarrier‐Mediated Cytosolic Delivery of Biopharmaceuticals. Adv Funct Mater 2020;30:1910566. [DOI: 10.1002/adfm.201910566] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Q, Li X, Liu C, Jiang Y, He Y, Zhang W, Azevedo HS, Wu W, Xia Y, He W. Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.012] [Reference Citation Analysis]
2 Zheng J, Wang Q, Shi L, Shi L, Li T. Calcium-Differentiated Cellular Internalization of Allosteric Framework Nucleic Acids for Targeted Payload Delivery. Anal Chem 2022. [PMID: 35709364 DOI: 10.1021/acs.analchem.2c01434] [Reference Citation Analysis]
3 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
4 Wang Y, Zeng S, Cui H, Li H, Li Z, Wang J, Chen Q. Reversible Chemical Protein Modification to Endogenous Glutathione and Its Utilities in the Manufacture of Transcellular Pro-Enzymes. Biomacromolecules 2022. [PMID: 35471918 DOI: 10.1021/acs.biomac.2c00152] [Reference Citation Analysis]
5 Luther DC, Lee YW, Nagaraj H, Clark V, Jeon T, Goswami R, Gopalakrishnan S, Fedeli S, Jerome W, Elia JL, Rotello VM. Cytosolic Protein Delivery Using Modular Biotin-Streptavidin Assembly of Nanocomposites. ACS Nano 2022. [PMID: 35435664 DOI: 10.1021/acsnano.1c06768] [Reference Citation Analysis]
6 Mazloum-Ravasan S, Mohammadi M, Hiagh EM, Ebrahimi A, Hong JH, Hamishehkar H, Kim KH. Nano-liposomal zein hydrolysate for improved apoptotic activity and therapeutic index in lung cancer treatment. Drug Deliv 2022;29:1049-59. [PMID: 35363101 DOI: 10.1080/10717544.2022.2057618] [Reference Citation Analysis]
7 Chen J, Pan S, Zhou J, Lin Z, Qu Y, Glab A, Han Y, Richardson JJ, Caruso F. Assembly of Bioactive Nanoparticles via Metal-Phenolic Complexation. Adv Mater 2022;34:e2108624. [PMID: 34933398 DOI: 10.1002/adma.202108624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Niu Y, Yang H, Yu Z, Gao C, Ji S, Yan J, Han L, Huo Q, Xu M, Liu Y. Intervention with the Bone-Associated Tumor Vicious Cycle through Dual-Protein Therapeutics for Treatment of Skeletal-Related Events and Bone Metastases. ACS Nano 2022;16:2209-23. [PMID: 35077154 DOI: 10.1021/acsnano.1c08269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wang L, Dai C, Fang Y, You X, Wu J. A drug/carrier dual redox-responsive system based on 6-mercaptopurine dimer-loaded cysteine polymer nanoparticles for enhanced lymphoma therapy. Nano Res . [DOI: 10.1007/s12274-021-4037-0] [Reference Citation Analysis]
10 Song T, Gao Y, Song M, Qian J, Zhang H, Zhou J, Ding Y. Fluoropolymers-mediated efficient biomacromolecule drug delivery. Medicine in Drug Discovery 2022. [DOI: 10.1016/j.medidd.2022.100123] [Reference Citation Analysis]
11 Zoulikha M, Xiao Q, Boafo GF, Sallam MA, Chen Z, He W. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Acta Pharm Sin B 2022;12:600-20. [PMID: 34401226 DOI: 10.1016/j.apsb.2021.08.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
12 Zhou H, You P, Liu H, Fan J, Tong C, Yang A, Jiang Y, Liu B. Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux. J Control Release 2021;341:828-43. [PMID: 34942304 DOI: 10.1016/j.jconrel.2021.12.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Shen M, Yao S, Li S, Wu X, Liu S, Yang Q, Du J, Wang J, Zheng X, Li Y. A ROS and shear stress dual-sensitive bionic system with cross-linked dendrimers for atherosclerosis therapy. Nanoscale 2021;13:20013-27. [PMID: 34842887 DOI: 10.1039/d1nr05355h] [Reference Citation Analysis]
14 Teng C, Li B, Lin C, Xing X, Huang F, Yang Y, Li Y, Azevedo HS, He W. Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension. J Control Release 2021;341:591-604. [PMID: 34896449 DOI: 10.1016/j.jconrel.2021.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Xiao L, Ding Z, Zhang X, Wang X, Lu Q, Kaplan DL. Silk Nanocarrier Size Optimization for Enhanced Tumor Cell Penetration and Cytotoxicity In Vitro. ACS Biomater Sci Eng 2021. [PMID: 34878245 DOI: 10.1021/acsbiomaterials.1c01122] [Reference Citation Analysis]
16 Zhang R, Nie T, Fang Y, Huang H, Wu J. Poly(disulfide)s: From Synthesis to Drug Delivery. Biomacromolecules 2021. [PMID: 34874705 DOI: 10.1021/acs.biomac.1c01210] [Reference Citation Analysis]
17 Wang H, Liu Y, Zhu X, Chen C, Fu Z, Wang M, Lin D, Chen Z, Lu C, Yang H. Multistage Cooperative Nanodrug Combined with PD-L1 for Enhancing Antitumor Chemoimmunotherapy. Adv Healthc Mater 2021;10:e2101199. [PMID: 34382363 DOI: 10.1002/adhm.202101199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zhu M. Immunological perspectives on spatial and temporal vaccine delivery. Adv Drug Deliv Rev 2021;178:113966. [PMID: 34506868 DOI: 10.1016/j.addr.2021.113966] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Navarro-Barreda D, Bedrina B, Galindo F, Miravet JF. Glutathione-responsive molecular nanoparticles from a dianionic bolaamphiphile and their use as carriers for targeted delivery. J Colloid Interface Sci 2021;608:2009-17. [PMID: 34752979 DOI: 10.1016/j.jcis.2021.10.142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sun M, Ji Z, He L, Zhao C, Ma L, Xu X, Cornel EJ, Fan Z, Xu X. Instant Intracellular Delivery of miRNA via Photothermal Effect Induced on Plasmonic Pyramid Arrays. Adv Funct Materials 2022;32:2107999. [DOI: 10.1002/adfm.202107999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Song Y, Su Q, Song H, Shi X, Li M, Song N, Lou S, Wang W, Yu Z. Precisely Shaped Self-Adjuvanting Peptide Vaccines with Enhanced Immune Responses for HPV-Associated Cancer Therapy. ACS Appl Mater Interfaces 2021;13:49737-53. [PMID: 34648269 DOI: 10.1021/acsami.1c15361] [Reference Citation Analysis]
22 Du X, Hou Y, Huang J, Pang Y, Ruan C, Wu W, Xu C, Zhang H, Yin L, He W. Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response. Acta Pharm Sin B 2021;11:3272-85. [PMID: 34729315 DOI: 10.1016/j.apsb.2021.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Su R, Chong G, Dong H, Gu J, Zang J, He R, Sun J, Zhang T, Zhao Y, Zheng X, Yang Y, Li Y, Li Y. Nanovaccine biomineralization for cancer immunotherapy: a NADPH oxidase-inspired strategy for improving antigen cross-presentation via lipid peroxidation. Biomaterials 2021;277:121089. [PMID: 34481292 DOI: 10.1016/j.biomaterials.2021.121089] [Reference Citation Analysis]
24 Wang Y, Hu LF, Zhou TJ, Qi LY, Xing L, Lee J, Wang FZ, Oh YK, Jiang HL. Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations. Biomaterials 2021;277:121108. [PMID: 34478929 DOI: 10.1016/j.biomaterials.2021.121108] [Reference Citation Analysis]
25 Li Y, Zhang C, Li G, Deng G, Zhang H, Sun Y, An F. Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy. Acta Pharm Sin B 2021;11:2220-42. [PMID: 34522585 DOI: 10.1016/j.apsb.2021.01.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
26 Wang X, Mohammad IS, Fan L, Zhao Z, Nurunnabi M, Sallam MA, Wu J, Chen Z, Yin L, He W. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B 2021;11:2585-604. [PMID: 34522599 DOI: 10.1016/j.apsb.2021.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
27 Khafaga AF, Shamma RN, Abdeen A, Barakat AM, Noreldin AE, Elzoghby AO, Sallam MA. Celecoxib repurposing in cancer therapy: molecular mechanisms and nanomedicine-based delivery technologies. Nanomedicine (Lond) 2021;16:1691-712. [PMID: 34264123 DOI: 10.2217/nnm-2021-0086] [Reference Citation Analysis]
28 Mastrobattista E. Formulation and delivery solutions for the next generation biotherapeutics. J Control Release 2021;336:583-97. [PMID: 34174354 DOI: 10.1016/j.jconrel.2021.06.029] [Reference Citation Analysis]
29 Wang F, Liu C, Wang C, Wang Y, Zang K, Wang X, Liu X, Li S, Li F, Ma Q. Structural basis of staphylococcal Stl inhibition on a eukaryotic dUTPase. Int J Biol Macromol 2021;184:821-30. [PMID: 34171258 DOI: 10.1016/j.ijbiomac.2021.06.107] [Reference Citation Analysis]
30 Li L, Zhang P, Li C, Guo Y, Sun K. In vitro/vivo antitumor study of modified-chitosan/carboxymethyl chitosan "boosted" charge-reversal nanoformulation. Carbohydr Polym 2021;269:118268. [PMID: 34294300 DOI: 10.1016/j.carbpol.2021.118268] [Reference Citation Analysis]
31 Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W. Biological drug and drug delivery-mediated immunotherapy. Acta Pharm Sin B 2021;11:941-60. [PMID: 33996408 DOI: 10.1016/j.apsb.2020.12.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 28.0] [Reference Citation Analysis]
32 Shen Q, Xu L, Li R, Wu G, Li S, Saw PE, Zhou Y, Xu X. A tumor microenvironment (TME)-responsive nanoplatform for systemic saporin delivery and effective breast cancer therapy. Chem Commun (Camb) 2021;57:2563-6. [PMID: 33586714 DOI: 10.1039/d0cc07808e] [Reference Citation Analysis]
33 Hami Z. A Brief Review on Advantages of Nano-based Drug Delivery Systems. Ann Mil Health Sci Res 2021;19. [DOI: 10.5812/amh.112274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Liang Y, Xie J, Yu J, Zheng Z, Liu F, Yang A. Recent advances of high performance magnetic iron oxide nanoparticles: Controlled synthesis, properties tuning and cancer theranostics. Nano Select 2021;2:216-50. [DOI: 10.1002/nano.202000169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 He W, Turkeshi A, Li X, Zhang H. Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles. Ther Deliv 2020;11:591-603. [PMID: 32933403 DOI: 10.4155/tde-2020-0052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
36 Teng C, Lin C, Huang F, Xing X, Chen S, Ye L, Azevedo HS, Xu C, Wu Z, Chen Z, He W. Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease. Acta Pharm Sin B 2020;10:1521-33. [PMID: 32963947 DOI: 10.1016/j.apsb.2020.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
37 Kopeček J, Yang J. Polymer nanomedicines. Adv Drug Deliv Rev 2020;156:40-64. [PMID: 32735811 DOI: 10.1016/j.addr.2020.07.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]